Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study. (Q52017561)

19 April 2018

title

Preclinical cognitive decline in late middle-aged asymptomatic apolipoprotein E-e4/4 homozygotes: a replication study. (English)

1 reference

19 April 2018

10

Alexander GE

1 reference

19 April 2018

author name string

Caselli RJ

1

1 reference

19 April 2018

Osborne D

2

1 reference

19 April 2018

Reiman EM

3

1 reference

19 April 2018

Hentz JG

4

1 reference

19 April 2018

Barbieri CJ

5

1 reference

19 April 2018

Saunders AM

6

1 reference

19 April 2018

Hardy J

7

1 reference

19 April 2018

Graff-Radford NR

8

1 reference

19 April 2018

Hall GR

9

1 reference

19 April 2018

publication date

1 August 2001

1 reference

19 April 2018

Journal of the Neurological Sciences

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

1 reference

19 April 2018

volume

189

1 reference

19 April 2018

issue

1-2

1 reference

19 April 2018

page(s)

93-98

1 reference

19 April 2018

Working-memory capacity, age, and memory for discourse

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Aging, Divided Attention, and Processing Capacity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Effects of human aging on patterns of local cerebral glucose utilization determined by the [18F]fluorodeoxyglucose method.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Positron emission tomography studies of normal aging: a replication of PET III and 18-FDG using PET VI and 11-CDG

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Topography of cross-sectional and longitudinal glucose metabolic deficits in Alzheimer's disease. Pathophysiologic implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Posterior cingulate cortex in Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Preclinical memory decline in cognitively normal apolipoprotein E-epsilon4 homozygotes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Mild cognitive impairment: clinical characterization and outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Population-based norms for the Mini-Mental State Examination by age and educational level

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

The neural basis of the central executive system of working memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Patterns of brain activation in people at risk for Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

A longitudinal, behavioral study of senile dementia of the Alzheimer type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Lower cognitive performance in normal older adult male twins carrying the apolipoprotein E epsilon 4 allele.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Neuropsychological detection and characterization of preclinical Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Episodic memory changes are associated with the APOE-epsilon 4 allele in nondemented older adults.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease. A longitudinal prospective study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Memory function in very early Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Neuropsychological prediction of dementia and the absence of dementia in healthy elderly persons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Working memory and secondary memory deficits in Alzheimer's disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Primary memory and secondary memory in dementia of the Alzheimer type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Dementia and working memory.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Clinical and pathological evidence for a frontal variant of Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Alzheimer's disease: cell-specific pathology isolates the hippocampal formation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

The role of apolipoprotein E in Alzheimer's disease, acute brain injury and cerebrovascular disease: evidence of common mechanisms and utility of animal models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Apolipoprotein E polymorphism and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

Apo E allele frequencies in younger (age 42-50) vs older (age 65-90) women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0022-510X%2801%2900577-9

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0022-510X(01)00577-9

1 reference

19 April 2018

PubMed ID

11535238

1 reference

19 April 2018